Lyon Timothy D, Tollefson Matthew K, Shah Paras H, Bews Katherine, Frank Igor, Karnes R Jeffrey, Thompson R Houston, Habermann Elizabeth B, Boorjian Stephen A
Department of Urology, Mayo Clinic, Rochester, MN.
Department of Health Sciences Research, Mayo Clinic, Rochester, MN; Surgical Outcomes Program, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN.
Urol Oncol. 2018 Aug;36(8):361.e15-361.e21. doi: 10.1016/j.urolonc.2018.05.015. Epub 2018 Jun 7.
To determine whether the rate of venous thromboembolism (VTE) following radical cystectomy (RC) is changing overtime.
The American College of Surgeons National Surgical Quality Improvement Program database was used to identify patients who underwent RC for bladder cancer from 2011 to 2016. VTE was defined as pulmonary embolism or deep vein thrombosis within 30 days of RC. VTE rate by year was assessed using the Cochran-Armitage test for trend. Associations between patient features and VTE were evaluated with multivariable logistic regression.
A total of 8,241 patients undergoing RC were identified, of whom 348 (4.2%) were diagnosed with VTE. VTE was diagnosed at a median of 13 days (IQR: 7-19) after RC, with 171 (49%) occurring after hospital discharge. Notably, the rate of VTE after RC was found to significantly decrease over time, from 5.1% in 2011 to 2.8% in 2016 (P = 0.001). On multivariable analysis, clinical factors significantly associated with increased odds of VTE included congestive heart failure (odds ratio [OR] = 2.83, P = 0.01), prolonged operative time (OR: 1.48-1.56, P = 0.02-0.01), and receipt of a perioperative blood transfusion (OR = 1.27; P = 0.04). When postoperative complications were adjusted for, sepsis/septic shock (OR = 2.37, P<0.001) and perioperative infection (OR = 1.74, P<0.001) were likewise found to be associated with VTE.
The rate of VTE after RC significantly decreased in recent years, potentially reflecting improvements in perioperative care. The specific casual factors underlying this trend, in addition to efforts to address identified risk factors for VTE, warrant continued study.
确定根治性膀胱切除术后静脉血栓栓塞症(VTE)的发生率是否随时间变化。
利用美国外科医师学会国家外科质量改进计划数据库,识别2011年至2016年因膀胱癌接受根治性膀胱切除术的患者。VTE定义为根治性膀胱切除术后30天内发生的肺栓塞或深静脉血栓形成。采用 Cochr an - Armitage趋势检验评估每年的VTE发生率。通过多变量逻辑回归评估患者特征与VTE之间的关联。
共识别出8241例接受根治性膀胱切除术的患者,其中348例(4.2%)被诊断为VTE。VTE在根治性膀胱切除术后中位时间13天(四分位间距:7 - 19天)被诊断出来,其中171例(49%)发生在出院后。值得注意的是,根治性膀胱切除术后VTE的发生率随时间显著下降,从2011年的5.1%降至2016年的2.8%(P = 0.001)。多变量分析显示,与VTE发生几率增加显著相关的临床因素包括充血性心力衰竭(比值比[OR]=2.83,P = 0.01)、手术时间延长(OR:1.48 - 1.56,P = 0.02 - 0.01)以及围手术期输血(OR = 1.27;P = 0.04)。在对术后并发症进行校正后,同样发现脓毒症/脓毒性休克(OR = 2.37,P<0.001)和围手术期感染(OR = 1.74,P<0.001)与VTE相关。
近年来根治性膀胱切除术后VTE的发生率显著下降,这可能反映了围手术期护理的改善。除了努力应对已确定的VTE风险因素外,这一趋势背后的具体因果因素值得继续研究。